Article
A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example.
BMC cancer - 29 Jun 2009
Mohammadi Leila, Vreeswijk Maaike P, Oldenburg Rogier, van den Ouweland Ans, Oosterwijk Jan C, van der Hout Annemarie H, Hoogerbrugge Nicoline, Ligtenberg Marjolijn, Ausems Margreet G, van der Luijt Rob B, Dommering Charlotte J, Gille Johan J, Verhoef Senno, Hogervorst Frans B, van Os Theo A, Gómez García Encarna, Blok Marinus J, Wijnen Juul T, Helmer Quinta, Devilee Peter, van Asperen Christi J, van Houwelingen Hans C
Abstract excerpt
BACKGROUND: Assessment of the clinical significance of unclassified variants (UVs) identified in BRCA1 and BRCA2 is very important for genetic counselling. The analysis of co-segregation of the variant with the disease in families is a powerful tool for the classification of these variants. Statistical methods have been described in literature but these methods are not always easy to apply in a diagnostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
